Alternatively, we demonstrated that the injection of CXCL13 induced TLS formation accompanied by the inhibition of tumor growth in mouse models, and that CD4+ T cells were the major source of CXCL13 in human ovarian cancer TLS. Here, CD4 is linked to ovarian carcinoma.